Cypress Capital Management LLC (Wy) Clovis Oncology, Inc. Transaction History

Cypress Capital Management LLC (Wy)

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$0.63 - $2.96 $1,134 - $5,328	-1,800 Reduced 90.0%	200 $0
Q4 2019 Feb 03, 2020	BUY	$3.0 - $16.43 $3,450 - $18,894	1,150 Added 135.29%	2,000 $21,000
Q3 2018 Oct 31, 2018	SELL	$29.37 - $49.48 $19,090 - $32,161	-650 Reduced 43.33%	850 $25,000
Q1 2018 May 03, 2018	SELL	$50.12 - $67.72 $15,036 - $20,316	-300 Reduced 16.67%	1,500 $79,000
Q4 2017 Jan 31, 2018	SELL	$57.69 - $84.58 $14,422 - $21,145	-250 Reduced 12.2%	1,800 $122,000
Q3 2017 Nov 07, 2017	BUY	$67.17 - $84.81 $137,698 - $173,860	2,050	2,050 $169,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Cypress Capital Management LLC (Wy), based on Form 13F filings with the SEC.

Stay updated on Cypress Capital Management LLC (Wy) with notifications on news.